| Tom Peter Lapsa, MD | |
|
1475 Taney Ave, Suite 103, Frederick, MD 21702-4747 | |
| (301) 694-8344 | |
| (301) 846-7924 |
| Full Name | Tom Peter Lapsa |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 1475 Taney Ave, Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841366382 | NPI | - | NPPES |
| F662-0001 | Other | DC | NATIONAL CAPITAL BCBS |
| 184311700 | Medicaid | MD | |
| F662-0001 | Other | FEDERAL BCBS | |
| 5130 | Other | MD | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | D19903 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tom Peter Lapsa, MD 1475 Taney Ave, Suite 103, Frederick, MD 21702-4747 Ph: (301) 694-8344 | Tom Peter Lapsa, MD 1475 Taney Ave, Suite 103, Frederick, MD 21702-4747 Ph: (301) 694-8344 |
News Archive
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, will present promising clinical data for CMX001 in a late-breaker poster session at the Infectious Diseases Society of America (IDSA) 48th Annual Meeting.
In this Guardian "Global Development Professionals Network" blog post, Robert Steinglass, senior immunization adviser at John Snow, Inc., and immunization team leader for the USAID-funded Maternal and Child Health Integrated Program, writes about the importance of innovation to improving childhood immunization programs and health systems.
Concussion symptoms-such as loss of balance, hazy comprehension, sleep disturbance and ability to walk straight-can be reversed by a new type of magnetic stimulation, research at the University of Saskatchewan shows.
There is currently insufficient supply of donor organs to meet the demand for organ transplantations in the UK. The number of patients registered for a transplant continues to increase. In March 2008, 7,655 patients were on the active transplant list; 506 died in 2007-2008 while waiting for their transplant.
Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.
› Verified 5 days ago
Dr. Holly Michele Gross, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5283 Corporate Dr, Suite 201, Frederick, MD 21703 Phone: 301-662-4545 Fax: 301-662-4044 | |
Dr. James Anthony Busack, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 470 W Patrick St, Frederick, MD 21701 Phone: 301-668-2020 Fax: 301-620-8729 | |
Dr. Amy Lynn Nicholas, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5283 Corporate Dr Ste 201, Frederick, MD 21703 Phone: 301-662-4545 Fax: 301-662-4044 | |
Dr. Louis Edward Perraut, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 70 Thomas Johnson Dr, Suite 120, Frederick, MD 21702 Phone: 240-575-9713 Fax: 240-575-9792 | |
Dr. Philip J Mcgann, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1003 W 7th St, Suite 400, Frederick, MD 21701 Phone: 301-662-3721 Fax: 301-631-5668 | |
Robert Bruce Hodges, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 201 Thomas Johnson Dr, Suite 100, Frederick, MD 21702 Phone: 301-682-3639 Fax: 301-682-9083 | |
Mr. Jeremy Jakob Wood, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 470 W Patrick St, Frederick, MD 21701 Phone: 301-668-2020 Fax: 301-620-8729 |